Skip to search formSkip to main contentSkip to account menu

Gardasil

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
GARDASIL 9 (Human Papillomavirus 9-Valent Vaccine, Recombinant).
GARDASIL 9 (Human Papillomavirus 9 -valent Vaccine, Recombinant) Suspension for intramuscular injection Initial U.S. Approval… 
Review
2016
Review
2016
Prevention of cervical cancer: journey to develop the first human papillomavirus virus-like particle vaccine and the next generation vaccine.
Highly Cited
2015
Highly Cited
2015
Immunogenicity and safety of Gardasil among mid-adult aged men (27-45 years)--The MAM Study.
Highly Cited
2014
Highly Cited
2014
Comparison of the immunogenicity and reactogenicity of Cervarix and Gardasil human papillomavirus vaccines in HIV-infected adults: a randomized, double-blind clinical trial.
BACKGROUND We compared the immunogenicity and reactogenicity of Cervarix or Gardasil human papillomavirus (HPV) vaccines in… 
2010
2010
Development of a novel viral DNA vaccine against human papillomavirus: AcHERV-HP16L1.
Highly Cited
2008
Highly Cited
2008
Evolution of type-specific immunoassays to evaluate the functional immune response to GARDASIL®, a vaccine for Human Papillomavirus types 16, 18, 6, and 11
Epidemiological studies and clinical trials of vaccines depend on the accurate measurement of antibodies within the polyclonal… 
Review
2008
Review
2008
A novel vaccine for cervical cancer: quadrivalent human papillomavirus (types 6, 11, 16 and 18) recombinant vaccine (Gardasil®)
Human papillomaviruses (HPVs) are one of the most common sexually transmitted infections and remains a public health problem… 
Review
2007
Review
2007
Developing an HPV vaccine to prevent cervical cancer and genital warts.
Highly Cited
2006
Highly Cited
2006
Evaluation of the Thermal Stability of Gardasil®
The thermostability of GARDASIL® (Merck & Co., Inc, Whtehouse Station, NJ, USA), a developmental vaccine against human… 
Highly Cited
2005
Highly Cited
2005
Correlation between Mouse Potency and In Vitro Relative Potency for Human Papillomavirus Type 16 Virus-Like Particles and Gardasil® Vaccine Samples
An in vitro relative potency (IVRP) assay has been developed as an alternative to the mouse potency assay used to release Merck’s… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)